Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report)'s stock price hit a new 52-week high on Thursday . The company traded as high as $4.02 and last traded at $3.86, with a volume of 10742237 shares trading hands. The stock had previously closed at $3.59.
Clover Health Investments Stock Performance
The stock has a market capitalization of $1.99 billion, a price-to-earnings ratio of -11.76 and a beta of 2.13. The firm's fifty day simple moving average is $2.65 and its 200 day simple moving average is $1.58.
Clover Health Investments (NASDAQ:CLOV - Get Free Report) last announced its earnings results on Monday, August 5th. The company reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.05. The firm had revenue of $356.26 million for the quarter, compared to the consensus estimate of $338.70 million. Clover Health Investments had a negative net margin of 7.30% and a negative return on equity of 36.55%. During the same period last year, the company posted ($0.06) EPS. Analysts forecast that Clover Health Investments, Corp. will post -0.13 earnings per share for the current year.
Institutional Trading of Clover Health Investments
Several hedge funds have recently bought and sold shares of CLOV. Viewpoint Capital Management LLC grew its stake in shares of Clover Health Investments by 96.8% during the 2nd quarter. Viewpoint Capital Management LLC now owns 30,500 shares of the company's stock worth $38,000 after acquiring an additional 15,000 shares in the last quarter. Jaffetilchin Investment Partners LLC grew its stake in shares of Clover Health Investments by 30.2% in the first quarter. Jaffetilchin Investment Partners LLC now owns 49,741 shares of the company's stock valued at $39,000 after buying an additional 11,550 shares in the last quarter. Vanguard Personalized Indexing Management LLC grew its stake in shares of Clover Health Investments by 54.4% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 34,372 shares of the company's stock valued at $42,000 after buying an additional 12,104 shares in the last quarter. Marshall Wace LLP bought a new position in shares of Clover Health Investments in the second quarter valued at $55,000. Finally, Allspring Global Investments Holdings LLC grew its stake in shares of Clover Health Investments by 151.2% in the first quarter. Allspring Global Investments Holdings LLC now owns 77,948 shares of the company's stock valued at $62,000 after buying an additional 46,912 shares in the last quarter. 19.77% of the stock is currently owned by institutional investors and hedge funds.
About Clover Health Investments
(
Get Free Report)
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
See Also
Before you consider Clover Health Investments, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clover Health Investments wasn't on the list.
While Clover Health Investments currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
